# Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System

Study · id `cardio:ct-nct07300358` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07300358](<https://clinicaltrials.gov/study/NCT07300358>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07300358

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 258 participants.

## Technical summary

Registry record NCT07300358. Randomized; triple masking; primary purpose prevention. Start 2025-12-30 (anticipated); primary completion 2027-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 258 participants (planned count; ClinicalTrials.gov record NCT07300358, source copy `cardio:ctgov-nct07300358-2025-12-23`, retrieved 2026-10-26)
- Planned start: 2025-12-30 (anticipated) (ClinicalTrials.gov record NCT07300358, source copy `cardio:ctgov-nct07300358-2025-12-23`, retrieved 2026-10-26)
- Primary completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT07300358, source copy `cardio:ctgov-nct07300358-2025-12-23`, retrieved 2026-10-26)
- Completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT07300358, source copy `cardio:ctgov-nct07300358-2025-12-23`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07300358-2025-12-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System
- Acronym: BIOCLOSE-PFO
- Condition: Cardiovascular Diseases
- Condition: Cardiovascular Abnormality
- Condition: Heart Defects, Congenital
- Condition: Heart Septal Defects
- Condition: Heart Septal Defects, Atrial
- Condition: Foramen Ovale, Patent
- Condition: Stroke, Ischemic
- Condition: Stroke (CVA) or TIA
- Intervention (Device): Active Comparator
- Intervention (Device): Experimental
- Lead sponsor: Shanghai Lingsi Medical Technology Co., Ltd.
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Adult congenital heart disease (`cardio:adult-congenital-heart-disease`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 90aab07dd204c55da4a7b4370730e2b8fecf4dbc567ac7fbf2e1ae00e3ef1abb
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
